Page 21 - CBAC Newsletter 2016

38. Sahu ID, Craig AF, Dunagan MM, Troxel KR, Zhang R, Meiberg AG, Harmon CN, McCarrick RM, Kroncke BM,
Sanders CR, Lorigan,GA. Probing Structural Dynamics and Topology of the KCNE1 Membrane Protein in
Lipid Bilayers via Site-Directed Spin Labeling and Electron Paramagnetic Resonance Spectroscopy.
Biochemistry. 54, 6402-6412, 2015.
39. Sahu ID, Kroncke BM, Zhang R, Dunagan MM, Smith HJ, Craig A, McCarrick RM, Sanders CR, Lorigan GA.

Structural investigation of the transmembrane domain of KCNE1 in proteoliposomes. Biochemistry. 53,
6392-6401, 2014
40. Poulsen AN, Klaerke DA. The KCNE1 beta-subunit exerts a transient effect on the KCNQ1 K+ channel.
Biochem Biophys Res Commun. 363, 133-139, 2007.
41. Nakajo K, Ulbrich MH, Kubo Y, Isacoff EY. Stoichiometry of the KCNQ1 - KCNE1 ion channel complex.
Proc. Natl. Acad. Sci. USA. 107, 18862-18867, 2010.
42. Pusch M, Bertorello L, Conti F. Gating and flickery block differentially affected by rubidium in homomeric
KCNQ1 and heteromeric KCNQ1/KCNE1 potassium channels. Biophys. J. 78, 211-226, 2000.
43. Zaydman MA, Kasimova MA, McFarland K, Beller Z, Hou P, Kinser HE, Liang H, Zhang G, Shi J, Tarek M, Cui J.
Domain-domain interactions determine the gating, permeation, pharmacology, and subunit modulation of
the IKs ion channel. eLife. 3, e03606, 2014.
44. Melman YF, Um SY, Krumerman A, Kagan A, McDonald TV. KCNE1 binds to the KCNQ1 pore to regulate
potassium channel activity. Neuron. 42, 927-937, 2004.
45. Seebohm G, Pusch M, Chen J, Sanguinetti MC. Pharmacological activation of normal and
arrhythmia-associated mutant KCNQ1 potassium channels. Circ. Res. 93, 941-947, 2003.
46. Unsold B, Kerst G, Brousos H, Hubner M, Schreiber R, Nitschke R, Greger R, Bleich M. KCNE1 reverses the
response of the human K+ channel KCNQ1 to cytosolic pH changes and alters its pharmacology and
sensitivity to temperature. Pflugers Arch. 441, 368-378, 2000.
47. Ismailov II, Benos DJ. Effects of phosphorylation on ion channel function. Kidney Int. 48, 1167-1179, 1995.
48. Nicolas CS, Park KH, El Harchi A, Camonis J, Kass RS, Escande D, Merot J, Loussouarn G, Le Bouffant F,
Baro I. IKs response to protein kinase A-dependent KCNQ1 phosphorylation requires direct interaction
with microtubules. Cardiovasc. Res. 79, 427-435, 2008.
49. Piippo K, Swan H, Pasternack M, Chapman H, Paavonen K, Viitasalo M, Toivonen L, Kontula K. A founder
mutation of the potassium channel KCNQ1 in long QT syndrome: implications for estimation of disease
prevalence and molecular diagnostics. J Am Coll Cardiol. 37, 562-568, 2001.
50. Splawski I, Timothy KW, Vincent GM, Atkinson DL, Keating MT. Molecular basis of the long-QT syndrome

associated with deafness. N Engl J Med. 336, 1562-1567, 1997.
51. Neyroud N, Richard P, Vignier N, Donger C, Denjoy I, Demay L, Shkolnikova M, Pesce R, Chevalier P,

Hainque B, Coumel P, Schwartz K, Guicheney P. Genomic organization of the KCNQ1 K+ channel gene
and identification of C-terminal mutations in the long-QT syndrome. Circ Res. 84, 290-297, 1999.
52. Splawski I, Shen J, Timothy KW, Vincent GM, Lehmann MH, Keating MT. Genomic structure of three long QT
syndrome genes: KVLQT1, HERG, and KCNE1. Genomics. 51, 86-97, 1998.
53. Ackerman MJ, Tester DJ, Porter CJ, Edwards WD. Molecular diagnosis of the inherited long-QT syndrome in a
woman who died after near-drowning. N Engl J Med. 341, 1121-1125, 1999.
54. Modell SM, Lehmann MH. The long QT syndrome family of cardiac ion channelopathies: a HuGE review.
Genet. Med. 8, 143-155, 2006.
55. Bianchi L, Priori SG, Napolitano C, Surewicz KA, Dennis AT, Memmi M, Schwartz PJ, Brown AM. Mechanisms
of I(Ks) suppression in LQT1 mutants. Am J Physiol Heart Circ Physiol. 279, H3003-3011, 2000.
56. Wiwanitkit V. Mutation-prone points in KCNQ. Exp Clin Cardiol. 13, 139-140, 2008.

CBAC Center Heartbeat | 17